CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 150 enrolled
Drug / intervention
Additive classical homeopathy +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01509612
NCT01509612Phase 3Completed
CompareCT.gov

Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter Study Evaluating Quality of Life in Patients With Advanced Malignant Lung Tumors With or Without "add-on" Homeopathy

Medical University of Vienna·interventional·Posted Jan 13, 2012·Updated Jun 16, 2021

In Brief

A Phase 3 clinical trial evaluating Additive classical homeopathy and Homeopathic Placebo globules for Malignant Tumors. Completed, enrolled 150 participants across 1 site.

Detailed Summary

The investigators aim to investigate the validity of their previous results in a randomized prospective, placebo-controlled, double-blind, multicenter controlled evaluation of questionnaires in patients with advanced malignant tumors. The investigators plan to compare the treatment outcome (quality of life and survival) in tumor patients, receiving standard or "add-on" homeopathic treatment. The null hypothesis is that "add-on" homeopathic treatment does not create a benefit for cancer patients. In addition the investigators evaluate survival time.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalignant Tumors
CountriesAustria
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 13, 2012
Enrollment StartFeb 1, 2012
Primary CompletionJul 31, 2019
TodayJul 2, 2026
Enrollment to primary: 7.5 yearsPosted 14.5 years ago

Interventions

Additive classical homeopathydrug

Homeopathic remedies every 2 to 3 months

Homeopathic Placebo globulesdrug

Homeopathic placebo globules every 2 to 3 months